SREBF1 and metabolic dysfunction-associated steatotic liver disease: Jung et al., (2013) observed that the incubation of hepatocytes with palmitate, a model of NAFLD in vitro, induced upregulation of the fetuin-A expression in hepatocytes, accompanied by triglyceride accumulation and the induction of SREBP-1c.